Skip to main content
Concord Biotech Limited (NSE:CONCORDBIO)
India flag India · Delayed Price · Currency is INR
1,522.00
-21.60 (-1.40%)
May 12, 2025, 2:30 PM IST

Revenue by Product

Fiscal year is April - March.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
 Mar '23 Mar '22 Mar '21 Mar '20 Mar '19
Active Pharmaceutical Ingredients
8.28B
Log In
Log In
Log In
Log In
Active Pharmaceutical Ingredients Growth
8.76%
Log In
Log In
Log In
Log In
Formulations
1.89B
Log In
Log In
Log In
Log In
Formulations Growth
105.66%
Log In
Log In
Log In
Log In
Bulk Drug
-
Log In
Log In
Log In
Log In
Bulk Drug Growth
-
Log In
Log In
Log In
Log In

Revenue by Geography

Fiscal year is April - March.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
 Mar '23 Mar '22 Mar '21 Mar '20 Mar '19
India
5.34B
Log In
Log In
Log In
Log In
India Growth
23.62%
Log In
Log In
Log In
Log In
America
1.08B
Log In
Log In
Log In
Log In
America Growth
-26.67%
Log In
Log In
Log In
Log In
Other
3.75B
Log In
Log In
Log In
Log In
Other Growth
36.88%
Log In
Log In
Log In
Log In